Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure
Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure have?
Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure has 540 citations in the OpenAlex counts ScholarIQ stores.
When was Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure published?
Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure has 2003 year in the ScholarIQ index.
What is the open-access status of Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure?
Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure has bronze oa status in the ScholarIQ index.
What is the DOI of Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure?
The DOI for Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure is on the source record.
What is the PMID of Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure?
The PMID for Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure is on the source record.
What is the OpenAlex record for Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure?
The OpenAlex for Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure is on the source record.